Cost-effectiveness of consolidation durvalumab for inoperable stage III non-small cell lung cancer in Vietnam
Background This study aimed to assess the cost-effectiveness of durvalumab as a treatment option for patients with inoperable stage III non-small cell lung cancer (NSCLC) from healthcare and partial societal perspectives in Vietnam.Method A lifetime partitioned survival model was used to evaluate th...
Saved in:
| Main Authors: | Hoang Van Minh, Lars Lindholm, Kim Bao Giang, Vu Quynh Mai, Sun Sun, Klas-Göran Sahlén |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-09-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/8/e083895.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acceptability of the use of health related quality of life measurements for decision-making in healthcare science in Vietnam: a qualitative study
by: Hoang Van Minh, et al.
Published: (2024-09-01) -
Research on Horizontal Coefficient of Consolidation of Vietnam’s Soft Soil
by: Nu Nguyen Thi, et al.
Published: (2020-01-01) -
Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations
by: Jason C.S. Ho, et al.
Published: (2024-01-01) -
Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 0120)
by: Mauro Zukin, et al.
Published: (2025-01-01) -
TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer
by: Peter Schmid, et al.
Published: (2025-04-01)